NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

This study has been completed.
Information provided by (Responsible Party):
NOXXON Pharma AG Identifier:
First received: February 27, 2012
Last updated: February 21, 2014
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)